Re: “Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives” by Zhu et al.: Clinical Factors Affecting Patients’ Decision Between Active Surveillance and Surgery: A Surgeon’s View from China
Restricted accessResearch articleFirst published online December, 2023
Re: “Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives” by Zhu et al.: Clinical Factors Affecting Patients’ Decision Between Active Surveillance and Surgery: A Surgeon’s View from China
ZhuP, ZhangQ, WuQ, et al.Barriers and facilitators to the choice of active surveillance for low-risk papillary thyroid cancer in China: A qualitative study examining patient perspectives. Thyroid, 2023; 33(7):826–834; doi: 10.1089/thy.2022.0347
2.
SugitaniI, ItoY, TakeuchiD, et al.Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma. Thyroid, 2021; 31(2):183–192; doi: 10.1089/thy.2020.0330
3.
PittSC, SauckeMC, RomanBR, et al.The influence of emotions on treatment decisions about low-risk thyroid cancer: A qualitative study. Thyroid, 2021; 31(12):1800–1807; doi: 10.1089/thy.2021.0323
4.
MalandrinoP, PellegritiG, AttardM, et al.Papillary thyroid microcarcinomas: A comparative study of the characteristics and risk factors at presentation in two cancer registries. J Clin Endocrinol Metab, 2013; 98(4):1427–1434; doi: 10.1210/jc.2012-3728
5.
YuXM, WanY, SippelRS, et al.Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg, 2011; 254(4):653–660; doi: 10.1097/SLA.0b013e318230036d
